Bowlero (NYSE:BOWL) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.17 by 17.65 percent. This is a 180 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $273.38 million which beat the analyst consensus estimate of $257.90 million by 6.00 percent. This is a 33.24 percent increase over sales of $205.19 million the same period last year.
Citigroup Initiates Coverage On Beam Therapeutics with Buy Rating, Announces Price Target of $62
Citigroup analyst Samantha Semenkow initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Buy rating and announces Price Target of $62.
